Einträge von Coch, Christoph auf dem Publikationsserver

Heidegger, Simon , Stritzke, Florian, Dahl, Sarah, Daßler-Plenker, Juliane, Joachim, Laura, Buschmann, Dominik, Fan, Kaiji, Sauer, Carolin M., Ludwig, Nils, Winter, Christof, Enssle, Stefan, Li, Suqi, Perl, Markus, Görgens, André, Haas, Tobias, Orberg, Erik Thiele, Göttert, Sascha, Wölfel, Catherine, Engleitner, Thomas, Cortés-Ciriano, Isidro, Rad, Roland, Herr, Wolfgang, Giebel, Bernd, Ruland, Jürgen , Bassermann, Florian, Coch, Christoph, Hartmann, Gunther und Poeck, Hendrik (2023) Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy. Cell Reports Medicine, S. 101171.

Tzaridis, Theophilos , Weller, Johannes, Bachurski, Daniel , Shakeri, Farhad , Schaub, Christina, Hau, Peter, Buness, Andreas, Schlegel, Uwe, Steinbach, Joachim‐Peter, Seidel, Clemens, Goldbrunner, Roland, Schäfer, Niklas, Wechsler‐Reya, Robert J., Hallek, Michael , Scheffler, Björn, Glas, Martin, Haeberle, Lothar, Herrlinger, Ulrich, Coch, Christoph, Reiners, Katrin S. und Hartmann, Gunther (2023) A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. International Journal of Cancer 152 (2), S. 308-319. Volltext nicht vorhanden.

Güresir, Erdem, Lampmann, Tim , Bele, Sylvia, Czabanka, Marcus, Czorlich, Patrick , Gempt, Jens, Goldbrunner, Roland, Hurth, Helene, Hermann, Elvis, Jabbarli, Ramazan, Krauthausen, Marius, König, Ralph, Lindner, Dirk, Malinova, Vesna, Meixensberger, Jürgen, Mielke, Dorothee, Németh, Robert, Darkwah Oppong, Marvin , Pala, Andrej, Prinz, Vincent, Rashidi, Ali, Roder, Constantin, Sandalcioglu, Ibrahim Erol, Sauvigny, Thomas, Schebesch, Karl-Michael, Timmer, Marco, Vajkoczy, Peter, Wessels, Lars, Wild, Florian, Wilhelm, Christoph, Wostrack, Maria , Vatter, Hartmut und Coch, Christoph (2023) Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial. International Journal of Stroke 18 (2), S. 242-247. Volltext nicht vorhanden.

Güresir, Erdem, Lampmann, Tim, Brandecker, Simon, Czabanka, Marcus, Fimmers, Rolf, Gempt, Jens, Haas, Patrick, Haj, Amer, Jabbarli, Ramazan, Kalasauskas, Darius, König, Ralph, Mielke, Dorothee, Németh, Robert, Oppong, Marvin Darkwah , Pala, Andrej, Prinz, Vincent, Ringel, Florian, Roder, Constantin, Rohde, Veit, Schebesch, Karl-Michael, Wagner, Arthur , Coch, Christoph und Vatter, Hartmut (2022) PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial. Trials 23 (1). Volltext nicht vorhanden.

Tzaridis, Theophilos , Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich und Felsberg, Jörg (2021) MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial. International Journal of Cancer 148 (7), S. 1695-1707. Volltext nicht vorhanden.

Weller, Johannes , Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert , Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich und Schäfer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology 20 (10), S. 1444-1453. Volltext nicht vorhanden.

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter , Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Bähr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh , Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert , Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schäfer, Niklas, Kebir, Sied, Weller, Johannes , Schaub, Christina, Stummer, Walter, Tonn, Jörg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang , Weller, Michael , Fimmers, Rolf, Schmid, Matthias , Hattingen, Elke , Pietsch, Torsten, Coch, Christoph und Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), S. 678-688. Volltext nicht vorhanden.